ANGELINA STRICKLAND: Open Payments
NPI 1497005573 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,451 in 97 payments from 16 companies in 2025. Trend: 2023 $2,627 · 2024 $3,430 · 2025 $2,451
Food & beverage: $2,451
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 20 | $561 |
| Alkermes, Inc. | 10 | $223 |
| Axsome Therapeutics, Inc. | 3 | $220 |
| ABBVIE INC. | 11 | $197 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $192 |
| Otsuka America Pharmaceutical, Inc. | 12 | $157 |
| Supernus Pharmaceuticals, Inc. | 6 | $152 |
| Janssen Pharmaceuticals, Inc | 5 | $151 |
| ABIOMED | 1 | $143 |
| Novo Nordisk Inc | 2 | $134 |
Products named: HETLIOZ, REXULTI, Auvelity, VRAYLAR, CAPLYTA, Qelbree, SPRAVATO, VIVITROL.
Industry payments across KY — which companies pay providers there.
